References
- FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer2005516117115738981
- MitraSGaurUGhoshPCMaitraANTumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrierJ Control Release20017431732311489513
- AcharyaSSahooSKPLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdv Drug Del Rev201163170183
- PotineniALynnDMLangerRAmijiMMPoly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel deliveryJ Control Release20038622323412526819
- LeslieEMDeeleyRGColeSPCMultidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defenseToxicol Appl Pharmacol200520421623715845415
- vanHelvoortASmithAJSprongHMDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholineCell1996875075178898203
- IffertTSoldanMMoellerAMaserEModulation of daunorubicin toxicity by liposomal encapsulation and use of specific inhibitors in vitroToxicology200014418919510781887
- DuanXPXiaoJSYinQSmart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiramACS Nano201375858586923734880
- LipmanJJardineIRoosCDreostiLIntravenous calcium-chloride as an antidote to verapamil-induced hypotensionIntens Care Med198285557
- BerdeauxACoutteRGiudicelliJFBoissierJREffects of verapamil on regional myocardial blood-flow and ST segment – role of induced bradycardiaEur J Pharmacol197639287294976324
- TangJLWangYJWangDKey structure of brij for overcoming multidrug resistance in cancerBiomacromolecules20131442443023311629
- WuHHaitWNYangJMSmall interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cellsCancer Res2003631515151912670898
- MengHALiongMXiaTAEngineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell lineACS Nano201044539455020731437
- NavarroGSawantRRBiswasSEssexSde IlarduyaCTTorchilinVPP-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cellsNanomedicine20127657822191778
- SaadMGarbuzenkoOBMinkoTCo-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancerNanomedicine2008376177619025451
- LuoYChenDWRenLXZhaoXLQinJSolid lipid nanoparticles for enhancing vinpocetine’s oral bioavailabilityJ Control Release2006114535916828192
- MinkoTBatrakovaEVLiSPluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cellsJ Control Release200510526927815939500
- ShiehMJHsuCYHuangLYChenHYHuangFHLaiPSReversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cellsJ Control Release201115241842521435362
- GrantRLYaoCGabaldonDAcostaDEvaluation of surfactant cytotoxicity potential by primary cultures of ocular-tissues: 1. characterization of rabbit corneal epithelial-cells and initial injury and delayed toxicity studiesToxicology1992761531761281345
- BansalTAkhtarNJaggiMKharRKTalegaonkarSNovel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulationDrug Discov Today2009141067107419647803
- WempeMFWrightCLittleJLInhibiting efflux with novel non-ionic surfactants: rational design based on vitamin E TPGSInt J Pharm20093709310219100824
- MaYLiuDWangDCombinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancerMol Pharm20141182623263024712391
- ZhuHChenHZengXCo-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistanceBiomaterials2014352391240024360574
- HongWChenDZhangXReversing multidrug resistance by intracellular delivery of Pluronic® P85 unimersBiomaterials2013349602961424021757
- GarriguesAEscargueilAEOrlowskiSThe multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membraneP Natl Acad Sci U S A2002991034710352
- dos SantosSMWeberCCFrankeCMullerWEEckertGPCholesterol: coupling between membrane microenvironment and ABC transporter activityBiochem Biophys Res Commun200735421622117223079
- CollnotEMBaldesCWempeMFMechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidityMol Pharm2007446547417367162
- XuHDengYHChenDWHongWWLuYDongXHEsterase-catalyzed depegylation of pH-sensitive vesicles modified with cleavable peg-lipid derivativesJ Control Release200813023824518657874
- HarrisJMStruckECCaseMGPaleyMSVanalstineJMBrooksDESynthesis and characterization of poly(ethylene glycol) derivativesJ Polym Sci Pol Chem198422341352
- ChiangWHHuangWCChangCWFunctionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imagingJ Control Release201316828028823562635
- LeeESNaKBaeYHDoxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJ Control Release200510340541815763623
- RuanJLTullochNLMuskheliVAn improved cryosection method for polyethylene glycol hydrogels used in tissue engineeringTissue Eng Part C Methods20131979480123448137
- HollisCPWeissHLLeggasMEversBMGemeinhartRALiTLBiodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug deliveryJ Control Release2013172122123920039
- MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release20006527128410699287
- DuhemNDanhierFPreatVVitamin E-based nanomedicines for anti-cancer drug deliveryJ Control Release2014182334424631865
- NairHBSungBYYadavVRKannappanRChaturvediMMAggarwalBBDelivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancerBiochem Pharmacol2010801833184320654584
- AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm2008550551518672949
- LeeESGaoZGBaeYHRecent progress in tumor pH targeting nanotechnologyJ Control Release200813216417018571265
- ParkSYBaikHJOhYTOhKTYounYSLeeESA smart polysac-charide/drug conjugate for photodynamic therapyAngew Chem Int Ed Engl2011501644164721308923
- OhKTBaikHJLeeAHOhYTYounYSLeeESThe reversal of drug-resistance in tumors using a drug-carrying nanoparticular systemInt J Mol Sci2009103776379219865518
- KievitFMWangFYFangCDoxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitroJ Control Release2011152768321277920
- ChawlaJSAmijiMMBiodegradable poly(epsilon-caprolactone) nano-particles for tumor-targeted delivery of tamoxifenInt J Pharm200224912713812433441
- MullerRHRuhlDRungeSABiodegradation of solid lipid nanoparticles as a function of lipase incubation timeInt J Pharm1996144115121
- FuDDHornickCAModulation of lipid-metabolism at rat hepatic subcellular sites by female sex-hormonesBiochim Biophys Acta199512542672737857966
- SchweitzerJKSedgwickAED’Souza-SchoreyCARF6-mediated endocytic recycling impacts cell movement, cell division and lipid homeostasisSemin Cell Dev Biol201122394720837153
- LiscumLSturleySLIntracellular trafficking of Niemann-Pick C proteins 1 and 2: obligate components of subcellular lipid transportBiochim Biophys Acta20041685222715465423
- TacarOSriamornsakPDassCRDoxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systemsJ Pharm Pharmacol20136515717023278683
- YouHYJinJShuHQSmall interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cellsCancer Lett200928011011919299075
- BansalTJaggiMKharRKTalegaonkarSEmerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapyJ Pharm Pharm Sci200912467819470292
- SchwabDFischerHTabatabaeiAPoliSHuwylerJComparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discoveryJ Med Chem2003461716172512699389
- ChaudharyPMRoninsonIBExpression and activity of p-glycoprotein, a multidrug efflux pump, in human hematopoietic stem-cellsCell19916685941712673
- O’ConnorROoiMGMeillerJThe interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasiasCancer Chemoth Pharm20137113571368
- ZastreJJacksonJKWongWBurtHMMethoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activityJ Pharm Sci20079686487517094135
- SoccioREBreslowJLIntracellular cholesterol transportArterioscl Throm Vas20042411501160
- LiSDHuangLNanoparticles evading the reticuloendothelial system: role of the supported bilayerBiochim Biophys Acta200917882259226619595666